Conditions causing malabsorption, such as Crohns disease or celiac disease, may benefit from bypassing the compromised digestive system entirely
Vomiting Along with nausea, some people may experience vomiting when taking semaglutide
However, the metabolic changes they produceparticularly significant weight losscan indirectly influence menstrual regularity through well-established physiological pathways
1 2 Important safety information: Wegovy (semaglutide) is a prescription-only medication for the management of obesity and the reduction of cardiovascular risk
Vezzani A, French J, Bartfai T, Baram TZ
In this review article, we discuss the mechanistic and clinical synergies that make the combined use of GLP-1RAs and SGLT2is appealing in patients with T2DM